Zoetis Inc. (0M3Q.L)
0M3Q.L Stock Price Chart
Explore Zoetis Inc. interactive price chart. Choose custom timeframes to analyze 0M3Q.L price movements and trends.
0M3Q.L Company Profile
Discover essential business fundamentals and corporate details for Zoetis Inc. (0M3Q.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Pharmaceuticals
IPO Date
29 Jan 2018
Employees
13.80K
Website
https://www.zoetis.comCEO
Kristin C. Peck
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
0M3Q.L Financial Timeline
Browse a chronological timeline of Zoetis Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 4 May 2026
Upcoming earnings on 11 Feb 2026
Upcoming earnings on 3 Nov 2025
Upcoming earnings on 4 Aug 2025
Revenue estimate is $2.41B.
Dividend declared on 18 Jul 2025
A dividend of $0.50 per share was announced, adjusted to $0.50. The dividend will be paid on 3 Sept 2025.
Earnings released on 6 May 2025
EPS came in at $1.48 surpassing the estimated $1.41 by +4.96%, while revenue for the quarter reached $2.22B, missing expectations by -7.04%.
Dividend declared on 21 Apr 2025
A dividend of $0.50 per share was announced, adjusted to $0.50. The dividend was paid on 3 Jun 2025.
Earnings released on 13 Feb 2025
EPS came in at $1.29 falling short of the estimated $1.36 by -5.15%, while revenue for the quarter reached $2.32B, beating expectations by +0.78%.
Dividend declared on 21 Jan 2025
A dividend of $0.50 per share was announced, adjusted to $0.50. The dividend was paid on 4 Mar 2025.
Earnings released on 4 Nov 2024
EPS came in at $1.50 surpassing the estimated $1.46 by +2.74%, while revenue for the quarter reached $2.39B, beating expectations by +4.34%.
Dividend declared on 31 Oct 2024
A dividend of $0.43 per share was announced, adjusted to $0.43. The dividend was paid on 3 Dec 2024.
Earnings released on 6 Aug 2024
EPS came in at $1.37 falling short of the estimated $1.49 by -8.05%, while revenue for the quarter reached $2.36B, beating expectations by +2.10%.
Dividend declared on 18 Jul 2024
A dividend of $0.43 per share was announced, adjusted to $0.43. The dividend was paid on 4 Sept 2024.
Earnings released on 2 May 2024
EPS came in at $1.31 falling short of the estimated $1.35 by -2.96%, while revenue for the quarter reached $2.19B, beating expectations by +1.70%.
Dividend declared on 18 Apr 2024
A dividend of $0.43 per share was announced, adjusted to $0.43. The dividend was paid on 4 Jun 2024.
Earnings released on 14 Mar 2024
EPS came in at $1.14 falling short of the estimated $1.32 by -13.64%, while revenue for the quarter reached $2.21B, beating expectations by +1.13%.
Dividend declared on 18 Jan 2024
A dividend of $0.43 per share was announced, adjusted to $0.43. The dividend was paid on 1 Mar 2024.
Earnings released on 2 Nov 2023
EPS came in at $1.29 falling short of the estimated $1.36 by -5.15%, while revenue for the quarter reached $2.15B, missing expectations by -0.99%.
Dividend declared on 31 Oct 2023
A dividend of $0.38 per share was announced, adjusted to $0.38. The dividend was paid on 1 Dec 2023.
Earnings released on 8 Aug 2023
EPS came in at $1.45 surpassing the estimated $1.31 by +10.69%, while revenue for the quarter reached $2.18B, beating expectations by +1.12%.
Dividend declared on 20 Jul 2023
A dividend of $0.38 per share was announced, adjusted to $0.38. The dividend was paid on 1 Sept 2023.
Earnings released on 4 May 2023
EPS came in at $1.19 falling short of the estimated $1.25 by -4.80%, while revenue for the quarter reached $2.00B, missing expectations by -0.70%.
Dividend declared on 20 Apr 2023
A dividend of $0.38 per share was announced, adjusted to $0.38. The dividend was paid on 1 Jun 2023.
Earnings released on 14 Feb 2023
EPS came in at $0.99 falling short of the estimated $1.15 by -14.09%, while revenue for the quarter reached $2.04B, beating expectations by +1.85%.
Dividend declared on 19 Jan 2023
A dividend of $0.38 per share was announced, adjusted to $0.38. The dividend was paid on 1 Mar 2023.
Dividend declared on 31 Oct 2022
A dividend of $0.33 per share was announced, adjusted to $0.33. The dividend was paid on 1 Dec 2022.
Earnings released on 30 Sept 2022
EPS came in at $1.13 falling short of the estimated $1.24 by -8.87%, while revenue for the quarter reached $2.00B, missing expectations by -3.91%.
Dividend declared on 20 Jul 2022
A dividend of $0.33 per share was announced, adjusted to $0.33. The dividend was paid on 1 Sept 2022.
Earnings released on 30 Jun 2022
EPS came in at $1.12 falling short of the estimated $1.21 by -7.44%, while revenue for the quarter reached $2.05B, beating expectations by +1.30%.
Earnings released on 4 May 2022
EPS came in at $1.26 surpassing the estimated $1.23 by +2.44%, while revenue for the quarter reached $1.99B, beating expectations by +0.43%.
Dividend declared on 20 Apr 2022
A dividend of $0.33 per share was announced, adjusted to $0.33. The dividend was paid on 1 Jun 2022.
Earnings released on 15 Feb 2022
EPS came in at $0.87 falling short of the estimated $0.96 by -9.66%, while revenue for the quarter reached $1.97B, beating expectations by +1.79%.
Dividend declared on 19 Jan 2022
A dividend of $0.33 per share was announced, adjusted to $0.33. The dividend was paid on 1 Mar 2022.
Earnings released on 4 Nov 2021
EPS came in at $1.07, while revenue for the quarter reached $1.95B.
Dividend declared on 28 Oct 2021
A dividend of $0.25 per share was announced, adjusted to $0.25. The dividend was paid on 1 Dec 2021.
Earnings released on 30 Sept 2021
EPS came in at $1.16, while revenue for the quarter reached $1.99B.
Dividend declared on 20 Jul 2021
A dividend of $0.25 per share was announced, adjusted to $0.25. The dividend was paid on 1 Sept 2021.
Dividend declared on 20 Apr 2021
A dividend of $0.25 per share was announced, adjusted to $0.25. The dividend was paid on 1 Jun 2021.
Earnings released on 31 Mar 2021
EPS came in at $1.17, while revenue for the quarter reached $1.87B.
Dividend declared on 19 Jan 2021
A dividend of $0.25 per share was announced, adjusted to $0.25. The dividend was paid on 1 Mar 2021.
Earnings released on 31 Dec 2020
EPS came in at $0.75, while revenue for the quarter reached $1.81B.
Dividend declared on 20 Oct 2020
A dividend of $0.20 per share was announced, adjusted to $0.20. The dividend was paid on 1 Dec 2020.
Earnings released on 30 Sept 2020
EPS came in at $1.00, while revenue for the quarter reached $1.79B.
0M3Q.L Stock Performance
Access detailed 0M3Q.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.